We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+2.83%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$7.76B
AUM Growth
+$499M
(+6.9%)
Cap. Flow
+$366M
Cap. Flow
% of AUM
4.71%
Top 10 Holdings %
Top 10 Hldgs %
15.72%
Holding
1,667
New
74
Increased
571
Reduced
929
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$48.8M |
| 2 |
Healthpeak Properties
DOC
|
+$16.2M |
| 3 |
Clorox
CLX
|
+$16.1M |
| 4 |
Brown-Forman Class B
BF.B
|
+$14.4M |
| 5 |
Hormel Foods
HRL
|
+$14.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$36.9M |
| 2 |
Apple
AAPL
|
+$10.8M |
| 3 |
JPMorgan Chase
JPM
|
+$6.74M |
| 4 |
Microsoft
MSFT
|
+$6.53M |
| 5 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$5.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.62% |
| 2 | Technology | 13.27% |
| 3 | Financials | 13.22% |
| 4 | Consumer Staples | 11.59% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHSP
1426
DELISTED
Chesapeake Lodging Trust
CHSP
| $200K | ﹤0.01% |
8,618
-60
| -0.7% | -$1.45K |
|
1427
Coeur Mining
CDE
$16.3B
| $199K | ﹤0.01% |
18,691
+2,048
| +12% | +$16.1K |
|
1428
Karyopharm Therapeutics
KPTI
$163M
| $199K | ﹤0.01% |
1,977
+25
| +1% | +$3.25K |
|
|
PKY
1429
DELISTED
Parkway, Inc.
PKY
| $195K | ﹤0.01% |
11,640
-587
| -5% | -$9.71K |
|
|
SRCI
1430
DELISTED
SRC Energy Inc
SRCI
| $193K | ﹤0.01% |
29,007
+10,848
| +60% | +$73.5K |
|
|
PETX
1431
DELISTED
Aratana Therapeutics, Inc.
PETX
| $192K | ﹤0.01% |
30,392
+1,038
| +4% | +$6.68K |
|
|
KW
1432
DELISTED
Kennedy-Wilson Holdings
KW
| $191K | ﹤0.01% |
10,092
-1,269
| -11% | -$26.3K |
|
1433
Rambus
RMBS
$11.2B
| $191K | ﹤0.01% |
15,770
-872
| -5% | -$10.6K |
|
|
S
1434
DELISTED
Sprint Corporation
S
| $189K | ﹤0.01% |
41,707
+4,692
| +13% | +$17.4K |
|
|
HW
1435
DELISTED
Headwaters Inc
HW
| $189K | ﹤0.01% |
10,558
-164
| -2% | -$3.1K |
|
|
IMMU
1436
DELISTED
Immunomedics Inc
IMMU
| $188K | ﹤0.01% |
81,246
-690
| -0.8% | -$2.31K |
|
1437
Wendy's
WEN
$1.41B
| $187K | ﹤0.01% |
19,409
-3,007
| -13% | -$31.5K |
|
|
NYRT
1438
DELISTED
New York REIT, Inc.
NYRT
| $187K | ﹤0.01% |
2,022
+33
| +2% | +$3.19K |
|
|
EVER
1439
DELISTED
Everbank Financial Corp
EVER
| $187K | ﹤0.01% |
12,600
+755
| +6% | +$11.2K |
|
1440
Hope Bancorp
HOPE
$1.73B
| $184K | ﹤0.01% |
12,351
-1,120
| -8% | -$17.4K |
|
|
MRC
1441
DELISTED
MRC Global
MRC
| $184K | ﹤0.01% |
12,961
-811
| -6% | -$11.2K |
|
|
TIVO
1442
DELISTED
Tivo Inc
TIVO
| $184K | ﹤0.01% |
11,736
-273
| -2% | -$4.59K |
|
|
ATW
1443
DELISTED
Atwood Oceanics
ATW
| $184K | ﹤0.01% |
14,718
-1,195
| -8% | -$12.5K |
|
|
ESPR
1444
DELISTED
Esperion Therapeutics
ESPR
| $183K | ﹤0.01% |
18,533
+238
| +1% | +$3.94K |
|
|
CPE
1445
DELISTED
Callon Petroleum Company
CPE
| $182K | ﹤0.01% |
1,620
+559
| +53% | +$59.9K |
|
|
TVPT
1446
DELISTED
Travelport Worldwide Limited
TVPT
| $182K | ﹤0.01% |
14,137
+1,216
| +9% | +$16.3K |
|
|
GNCMA
1447
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
| $182K | ﹤0.01% |
11,511
+1,186
| +11% | +$19.4K |
|
1448
BioCryst Pharmaceuticals
BCRX
$2.42B
| $181K | ﹤0.01% |
63,843
+876
| +1% | +$2.72K |
|
|
QLGC
1449
DELISTED
QLOGIC CORP
QLGC
| $179K | ﹤0.01% |
12,130
+93
| +0.8% | +$1.26K |
|
1450
Rigel Pharmaceuticals
RIGL
$699M
| $178K | ﹤0.01% |
7,998
+414
| +5% | +$10.3K |
|
Similar funds
ProShare Advisors's Q2 2016 Portfolio in Review
As of Q2 2016, ProShare Advisors held 1,667 positions worth $7.76B, up 6.9% from $7.26B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
ProShare Advisors deployed $366M of net new capital in Q2 2016, opening 74 new positions and adding to 571 existing holdings. Its largest new stake was S&P Global: 454,450 shares worth $48.7M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $10.8M trimmed.
- ProShare Advisors's largest Q2 2016 buy was S&P Global: 454,450 shares worth $48.7M.
- ProShare Advisors added most to Healthpeak Properties in Q2 2016, an estimated $16.2M increase.
- ProShare Advisors's biggest Q2 2016 reduction was Apple, cutting an estimated $10.8M.
- ProShare Advisors fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $36.9M.
- ProShare Advisors's ten largest holdings make up 16% of its $7.76B portfolio in Q2 2016.
- ProShare Advisors opened 74 new positions and closed 86 in Q2 2016.
- ProShare Advisors's portfolio value rose 6.9% quarter-over-quarter to $7.76B.
Based on ProShare Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.